For research teamsHelp me find a study
Study directory

Bipolarity studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1909studies shown
Showing 493-504 of 1,909
Drug study icon
CompletedEUCTR 2005-005072-32

Is it possible to modify the course of manic relapse? A pilot study of the effectiveness of quetiapine in preventing the development of manic episodes in Bipolarity.

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugA study involving a medication or substance.
Countries
United Kingdom
Sponsor
Kings College London (IOP) / South London and Maudsley NHS Trust (Co-sponsorship)
Condition
Bipolarity
View study
Drug study icon
CompletedEUCTR 2004-001482-17

Olanzapine Versus Divalproex and Placebo in the Treatment of Mild to Moderate Mania Associated with Bipolarity type I.

This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.

In Lithuania
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrug
Countries
Lithuania
Sponsor
Eli Lilly and Company
Condition
Bipolarity
View study
Other study type icon
Not recruitingISRCTN75279027

Examination of a web-based Integrated Bipolar Parenting Intervention (IBPI) for bipolar parents of young children (aged 3-10)

This study is looking at whether a digital support tool can help people with bipolarity, Mental and Behavioural Disorders, or Bipolarity, unspecified. Participants take part in a digital support tool and complete follow-up assessments.

In United Kingdom
Why is this study shown?

This study is directly about Bipolarity.

BipolarityOther
Countries
United Kingdom
Sponsor
Lancaster University (UK)
Condition
Bipolarity
View study
Drug study icon
CompletedNCT00312494

Ziprasidone With Either Lithium or Divalproex for Bipolarity

This study is completed in the United States. It is testing ziprasidone With Either Lithium or Divalproex for Bipolarity.

Multiple locations, including Dothan
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Condition
Bipolarity
View study
Drug study icon
WithdrawnNCT01685151

Ramelteon Tablets for Bipolarity

This study was withdrawn. It is testing ramelteon Tablets for Bipolarity.

Location not clearly listed
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 75 Years
Countries
Sponsor
Takeda
Condition
Bipolarity
View study
Drug study icon
CompletedNCT00261443

Aripiprazole (Abilify) in people with Bipolar Mania

This study is completed in the United States, in France, in Brazil, .... It is testing aripiprazole (Abilify) for manic episodes in bipolarity.

Multiple locations, including Tuscaloosa
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugOver 18 Years
Countries
United States, France, Brazil, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Bipolarity
View study
Other study type icon
CompletedNCT00741299

The Association Between Tobacco Smoking and Bipolarity

This study is completed in Israel. It focuses on Bipolarity.

In Tirat HaCarmel
Why is this study shown?

This study is directly about Bipolarity.

BipolarityObservationalA study where researchers collect information without assigning a treatment.From 18 Years to 65 Years
Countries
Israel
Sponsor
Tirat Carmel Mental Health Center
Condition
Bipolarity
View study
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.